I was planning to update my model portfolios, but I think there’s a more immediate opportunity in biotech. Featuring a long interview with Andrew Craig on biotech tiddlers
I would be happier if it was a Trust rather than a fund.
Nice piece David. I'm not sure if you've seen but International Biotech and BBH have both geared up substantially since the start of the year. IBT has also upped its small cap exposure to about 15% from a normal 5%. Gearing + high small cap exposure is rare for them, as they are typically very conservative. Basically fits with what you're saying that some good opportunities have opened up in the sector.